Page 53 - AN-2-2

Advanced Neurology Seizures and CKD

https://doi.org/10.1007/s00401–015–1481–5 https://doi.org/10.1111/j.1523-1755.2004.00894.x
5. Dalmau J, Gleichman AJ, Hughes EG, et al., 2008, Anti- 16. Títoff V, Moury HN, Títoff IB, et al., 2019, Seizures,
NMDA-receptor encephalitis: Case series and analysis of the antiepileptic drugs, and CKD. Am J Kidney Dis, 73: 90–101.
effects of antibodies. Lancet Neurol, 7: 1091–1098.
https://doi.org/10.1053/j.ajkd.2018.03.021
https://doi.org/10.1016/S1474-4422(08)70224-2
17. Barnett MW, Larkman PM, 2007, The action potential. Pract
6. Titulaer MJ, McCracken L, Gabilondo I, et al., 2013, Neurol, 7: 192–197.
Treatment and prognostic factors for long-term outcome 18. Sokoloff L, 1999, Energetics of functional activation in
in patients with anti-NMDA receptor encephalitis: An
observational cohort study. Lancet Neurol, 12: 157–165. neural tissues. Neurochem Res, 24: 321–329.
https://doi.org/10.1023/a:1022534709672
https://doi.org/10.1016/S1474-4422(12)70310-1
19. Dietzel I, Heinemann U, Lux HD, 1989, Relations between
7. Petit-Pedrol M, Armangue T, Peng X, et al., 2014, Encephalitis
with refractory seizures, status epilepticus, and antibodies slow extracellular potential changes, glial potassium
to the GABAA receptor: A case series, characterization of buffering, and electrolyte and cellular volume changes
the antigen, and analysis of the effects of antibodies. Lancet during neuronal hyperactivity in cat brain. Glia, 2: 25–44.
Neurol, 13: 276–286. https://doi.org/10.1002/glia.440020104
https://doi.org/10.1016/S1474-4422(13)70299-0 20. Kiernan MC, Walters RJ, Andersen KV, et al., 2002, Nerve
excitability changes in chronic renal failure indicate membrane
8. Lancaster E, Dalmau J, 2012, Neuronal autoantigens-
pathogenesis, associated disorders and antibody testing. Nat depolarization due to hyperkalaemia. Brain, 125: 1366–1378.
Rev Neurol, 8: 380–390. https://doi.org/10.1093/brain/awf123
https://doi.org/10.1038/nrneurol.2012.99 21. Lacerda G, Krummel T, Hirsch E, 2010, Neurologic
presentations of renal diseases. Neurol Clin, 28: 45–59.
9. Sazgar M, 2021, Kidney disease and epilepsy. J Stroke
Cerebrovasc Dis, 30: 105651. https://doi.org/10.1016/j.ncl.2009.09.003
https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105651 22. Rosner MH, Husain-Syed F, Reis T, et al., 2021, Uremic
encephalopathy. Kidney Int, 101: 227–241.
10. Levin A, Stevens PE, Bilous RW, et al., 2012, Kidney disease:
Improving Global Outcomes (KDIGO) CKD Work Group. https://doi.org/10.1016/j.kint.2021.09.025
KDIGO 2012 clinical practice guideline for the evaluation 23. Abbott NJ, Patabendige AA, Dolman DE, et al., 2010,
and management of chronic kidney disease. Kidney Int Structure and function of the blood-brain barrier. Neurobiol
Suppl, 3: 1–50. Dis, 37: 13–25.
https://doi.org/10.1038/kisup.2012.73 https://doi.org/10.1016/j.nbd.2009.07.030
11. Anders HJ, Huber TB, Isermann B, et al., 2018, CKD in 24. Jing W, Jabbari B, Vaziri ND, 2018, Uremia induces
diabetes: Diabetic kidney disease versus nondiabetic kidney upregulation of cerebral tissue oxidative/inflammatory
disease. Nat Rev Nephrol, 14: 361–377. cascade, down-regulation of Nrf2 pathway and disruption
https://doi.org/10.1038/s41581-018-0001-y of blood brain barrier. Am J Transl Res, 10: 2137–2147.
12. Foreman KJ, Marquez N, Dolgert A, et al., 2018, Forecasting 25. Heidland A, Sebekova K, Klassen A, et al., 2010, Mechanisms
life expectancy, years of life lost, and all-cause and cause- of acute uremic encephalopathy: Early activation of Fos and
specific mortality for 250 causes of death: Reference and Fra-2 gene products in different nuclei/areas of the rat brain.
alternative scenarios for 2016-40 for 195 countries and J Ren Nutr, 20: S44–S50.
territories. Lancet, 392: 2052–2090. https://doi.org/10.1053/j.jrn.2010.05.011
https://doi.org/10.1016/S0140-6736(18)31694-5 26. Kim DM, Lee IH, Song CJ, 2016, Uremic encephalopathy:
13. Kalantar-Zadeh K, Jafar TH, Nitsch D, et al., 2021, Chronic MR imaging findings and clinical correlation. Am J
kidney disease. Lancet, 398: 786–802. Neuroradiol, 37: 1604–1609.
https://doi.org/10.1016/S0140-6736(21)00519-5 https://doi.org/10.3174/ajnr.A4776
14. Burn DJ, Bates D, 1998, Neurology and the kidney. J Neurol 27. Malek M, 2018, Brain consequences of acute kidney injury:
Neurosurg Psychiatry, 65: 810–821. Focusing on the hippocampus. Kidney Res Clin Pract,
37: 315–322.
http://dx.doi.org/10.1136/jnnp.65.6.810
https://doi.org/10.23876/j.krcp.18.0056
15. Eknoyan G, Lameire N, Barsoum R, et al., 2004, The burden
of kidney disease: Improving global outcomes. Kidney Int, 28. Zhang XM, Zhu J, 2011, Kainic acid-induced neurotoxicity:
66: 1310–1314. Targeting glial responses and glia-derived cytokines. Curr

https://doi.org/10.36922/an.314
V
Volume 2 Issue 2 (2023) olume 2 Issue 2 (2023) 27 https://doi.org/10.36922/an.314
27